Cardiovascular Outcomes of Patients With Type 2 Diabetes With Urinary Tract Infection Post Sodium-Glucose Cotransporter 2 Inhibitors Treatment: A Multicenter Observational Study.

Objectives: Urinary tract infection (UTI) is an adverse effect of sodium-glucose cotransporter 2 inhibitors (SGLT2i). However, its effect on cardiovascular outcomes in type 2 diabetes mellitus (T2DM) patients remains unclear.

Methods: This multicenter retrospective observational study included diabetes patients who received SGLT2 inhibitors (SGLT2i) between January 2016 and January 2019.